Skip to main content
Veterinary Medicines

GABBROVET 140 MG/ML SOLUTION FOR USE IN DRINKING WATER, MILK OR MILK REPLACER FOR PRE-RUMINANT CATTLE AND PIGS

Authorised
  • Paromomycin sulfate

Product identification

Medicine name:
GABBROVET 140 MG/ML SOLUTION FOR USE IN DRINKING WATER, MILK OR MILK REPLACER FOR PRE-RUMINANT CATTLE AND PIGS
Active substance:
  • Paromomycin sulfate
Target species:
  • Cattle
  • Pig
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Paromomycin sulfate
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for use in drinking water
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        20
        day
    • Pig
      • Meat and offal
        3
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA06
Authorisation status:
  • Valid
Authorised in:
This information is not available for this product.
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
Responsible authority:
  • Le Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V 915/18/05/1699
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0317/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."